Sex Dimorphism Profile of Alzheimer's Disease-Type Pathologies in an APP/PS1 Mouse Model

被引:89
|
作者
Jiao, Shu-Sheng [1 ]
Bu, Xian-Le [1 ]
Liu, Yu-Hui [1 ]
Zhu, Chi [1 ]
Wang, Qing-Hua [1 ]
Shen, Lin-Lin [1 ]
Liu, Cheng-Hui [1 ]
Wang, Ye-Ran [1 ]
Yao, Xiu-Qing [1 ]
Wang, Yan-Jiang [1 ]
机构
[1] Third Mil Med Univ, Daping Hosp, Dept Neurol, Chongqing, Peoples R China
基金
中国国家自然科学基金;
关键词
Alzheimer's disease; Sex dimorphism; Beta-amyloid; Cerebral amyloid angiopathy; Tau pathology; Neuroinflammation; Loss of neurons and synapses; HORMONE REPLACEMENT THERAPY; CEREBRAL AMYLOID ANGIOPATHY; GENDER-DIFFERENCES; TRANSGENIC MICE; OLDER WOMEN; BETA; DEMENTIA; ESTROGEN; PROTEINS; TAU;
D O I
10.1007/s12640-015-9589-x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease (AD) is the most common form of dementia among the elderly, characterized by parenchymal and vascular beta-amyloid (A beta) burden, tau pathology, neuroinflammation, and loss of neurons and synapses. There is a clear sex difference in the prevalence of AD. However, sex differences in AD-type pathologies have not been systematically documented. Applying 12-month-old female and male APP/PS1 mice as a model, we investigated the sex dimorphism in these major pathological indices. Compared with male APP/PS1 mice, the females exhibited higher parenchymal A beta burdens, with the sex difference in hippocampus being the most significant. Female APP/PS1 mice had more severe cerebral amyloid angiopathy and subsequent microhemorrhage. In addition, female APP/PS1 mice also showed higher levels of phosphorylated tau and proinflammatory cytokines, more severe astrocytosis and microgliosis, and greater neuronal and synaptic degenerations. The present study systematically described a sex dimorphism in AD-type pathologic indices, suggesting that gender should be taken into account in designing studies involving these pathological indices and when interpreting the relevant findings in those studies.
引用
收藏
页码:256 / 266
页数:11
相关论文
共 50 条
  • [1] Sex Dimorphism Profile of Alzheimer’s Disease-Type Pathologies in an APP/PS1 Mouse Model
    Shu-Sheng Jiao
    Xian-Le Bu
    Yu-Hui Liu
    Chi Zhu
    Qing-Hua Wang
    Lin-Lin Shen
    Cheng-Hui Liu
    Ye-Ran Wang
    Xiu-Qing Yao
    Yan-Jiang Wang
    Neurotoxicity Research, 2016, 29 : 256 - 266
  • [2] The long-term effects of intermittent theta burst stimulation on Alzheimer's disease-type pathologies in APP/PS1 mice
    Huang, Hao
    Zhu, Yang
    Liao, Lingyi
    Gao, Shihao
    Tao, Yong
    Fang, Xiangqin
    Lian, Yan
    Gao, Changyue
    BRAIN RESEARCH BULLETIN, 2023, 202
  • [3] Impact of chronic doxycycline treatment in the APP/PS1 mouse model of Alzheimer's disease
    Gomez-Murcia, Victoria
    Carvalho, Kevin
    Thiroux, Bryan
    Caillierez, Raphaelle
    Besegher, Melanie
    Sergeant, Nicolas
    Buee, Luc
    Faivre, Emile
    Blum, David
    NEUROPHARMACOLOGY, 2022, 209
  • [4] Milrinone Ameliorates the Neuroinflammation and Memory Function of Alzheimer's Disease in an APP/PS1 Mouse Model
    Chen, Qingyou
    Yin, Yue
    Li, Li
    Zhang, Yanjiao
    He, Wei
    Shi, Yan
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 2129 - 2139
  • [5] Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer’s disease
    Oliver Wirths
    Joachim Weis
    Jacek Szczygielski
    Gerd Multhaup
    Thomas A. Bayer
    Acta Neuropathologica, 2006, 111 : 312 - 319
  • [6] Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease
    Wirths, O
    Weis, J
    Szczygielski, J
    Multhaup, G
    Bayer, TA
    ACTA NEUROPATHOLOGICA, 2006, 111 (04) : 312 - 319
  • [7] High throughput multiorgan metabolomics in the APP/PS1 mouse model of Alzheimer's disease
    Gonzalez-Dominguez, Raul
    Garcia-Barrera, Tamara
    Vitorica, Javier
    Luis Gomez-Ariza, Jose
    ELECTROPHORESIS, 2015, 36 (18) : 2237 - 2249
  • [8] Neuroprotective Effects of Leptin on the APP/PS1 Alzheimer's Disease Mouse Model: Role of Microglial and Neuroinflammation
    Ma, Jing
    Hou, Yi-Hui
    Liao, Zhe-Yan
    Ma, Zheng
    Zhang, Xiao-Xuan
    Wang, Jian-Li
    Zhu, Yun-Bo
    Shan, Hai-Lei
    Wang, Ping-Yue
    Li, Cheng-Bo
    Lv, Ying-Lei
    Wei, Yi-Lan
    Dou, Jie-Zhi
    DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE, 2023, 13 : 69 - 79
  • [9] Multi-target PET evaluation in APP/PS1/tau mouse model of Alzheimer's disease
    Liu, Yu
    Xu, Yuping
    Li, Mingzhu
    Pan, Donghui
    Li, Yaoqi
    Wang, Yan
    Wang, Lizhen
    Wu, Qiong
    Yang, Min
    NEUROSCIENCE LETTERS, 2020, 728
  • [10] Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits
    Jiao, Shu-Sheng
    Yao, Xiu-Qing
    Liu, Yu-Hui
    Wang, Qing-Hua
    Zeng, Fan
    Lu, Jian-Jun
    Liu, Jia
    Zhu, Chi
    Shen, Lin-Lin
    Liu, Cheng-Hui
    Wang, Ye-Ran
    Zeng, Gui-Hua
    Parikh, Ankit
    Chen, Jia
    Liang, Chun-Rong
    Xiang, Yang
    Bu, Xian-Le
    Deng, Juan
    Li, Jing
    Xu, Juan
    Zeng, Yue-Qin
    Xu, Xiang
    Xu, Hai-Wei
    Zhong, Jin-Hua
    Zhou, Hua-Dong
    Zhou, Xin-Fu
    Wang, Yan-Jiang
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (16) : 5225 - 5230